Breaking News
Translate

Pfizer NEAR inaugurates cardiovascular advisory board

By SOLA OGUNDIPE
IN a bid to further strengthen its position as the market leader in cardiovascular  medicine, Pfizer, Nigeria East Africa Region (NEAR), has inaugurated a Cardiovascular Summit Faculty Board. The board, which is made up of eminent medical practitioners and facilitators at previous annual Cardiovascular Summits.

The Faculty Board is to serve in advisory capacity on  management and treatment of cardiovascular disorders within the region. Members would offer advice on relevant topics/modules and modalities for  future cardiovascular regional/district summits.

Margaret Olele, Pfizer’s Associate Director Public Affairs and Communication, noted in a statement that the Cardiovascular Summit is an educational platform for healthcare practitioners to engage in a robust discussion on latest trends in cardiovascular disease and its management.

“It is expected to ultimately encourage the use of general guidelines and recommendations, equip practitioners with update knowledge and skills for  management of cardiovascular disease in the environment and also provide a forum to highlight, discuss and recommend policies that will enhance better health care delivery to policy makers at all levels,” she said.

Olele recalled that the maiden  Cardiovascular Summit was in 2008 in Lagos. “In past editions, Pfizer  has witnessed the growing positive interest of the Summit as well as the high scientific consideration that health care providers have for this event. The Summit has also been endorsed by the Medical and Dental Council of Nigeria as a continuous professional development (CPD).

‘The Summit is part of Pfizer’s contribution to the advancement of medical knowledge and patient care in the NEAR region  by keeping healthcare professionals aware of new trends in medicine; the summit further exemplifies the commitment of Pfizer to world class medical education, capacity building and excellence in service to the Nigerian health sector.


Disclaimer

Comments expressed here do not reflect the opinions of vanguard newspapers or any employee thereof.